ClinVar Miner

Submissions for variant NM_000414.4(HSD17B4):c.868+1del

dbSNP: rs749532705
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000780346 SCV000917533 likely pathogenic Bifunctional peroxisomal enzyme deficiency 2018-06-25 criteria provided, single submitter clinical testing Variant summary: HSD17B4 c.868delG (p.Glu290AsnfsX6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.6e-05 in 245702 control chromosomes (gnomAD). To our knowledge, no occurrence of c.868delG in individuals affected with D-Bifunctional Protein Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Baylor Genetics RCV000780346 SCV001162970 pathogenic Bifunctional peroxisomal enzyme deficiency criteria provided, single submitter clinical testing
Invitae RCV001040699 SCV001204288 pathogenic Bifunctional peroxisomal enzyme deficiency; Perrault syndrome 2024-01-09 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (Splice site) in the HSD17B4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HSD17B4 are known to be pathogenic (PMID: 11810648, 16385454, 20673864). This variant is present in population databases (rs749532705, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with D-bifunctional protein deficiency (PMID: 32904102; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.868+1del. ClinVar contains an entry for this variant (Variation ID: 632857). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV000780346 SCV001984801 likely pathogenic Bifunctional peroxisomal enzyme deficiency 2020-09-04 criteria provided, single submitter clinical testing This frameshifting variant in exon 12 of 25 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has not been previously reported or functionally characterized in the literature to our knowledge. It is present in the heterozygous state in the gnomAD population database at a frequency of 0.002% (4/250944) and thus is presumed to be rare. Based on the available evidence, the c.943+1del variant is classified as Likely Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV002487606 SCV002786645 likely pathogenic Bifunctional peroxisomal enzyme deficiency; Perrault syndrome 1 2022-01-14 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004527810 SCV004105463 likely pathogenic HSD17B4-related disorder 2023-01-04 criteria provided, single submitter clinical testing The HSD17B4 c.868+1delG variant is predicted to result in a deletion affecting a canonical splice site. This variant was reported as pathogenic in a patient with D-bifunctional protein deficiency (Landau et al. 2020. PubMed ID: 32904102). This variant is reported in 0.012% of alleles in individuals of Latino descent in gnomAD ( This variant is interpreted as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.